Inventor · disambiguated record
Eric B. Springman
Also filed as: SPRINGMAN ERIC · SPRINGMAN ERIC B · SPRINGMAN ERIC BRUCE
10 granted patents·5 pending applications·24 citations·filing 2005–2024
84Inventor score
Top patents by PatentIndex Score
15 records- 0189US10898484B2Method of reducing pulmonary exacerbations in respiratory disease patientsCELLTAXIS LLC·Filed 2019·Granted Jan 26, 2021·5 cites·27 claims
- 0288US11890282B2Method of reducing pulmonary exacerbations in respiratory disease patientsCELLTAXIS LLC·Filed 2021·Granted Feb 6, 2024·2 cites·24 claims
- 0386US9820974B2Methods of inhibiting leukotriene A4 hydrolaseCELTAXSYS INC·Filed 2015·Granted Nov 21, 2017·9 cites·8 claims
- 0483US10350197B2Methods of inhibiting leukotriene A4 hydrolaseCELTAXSYS INC·Filed 2017·Granted Jul 16, 2019·5 cites·8 claims
- 0576US7612200B2Inhibitors of protein kinasesLOCUS PHARMACEUTICALS INC·Filed 2005·Granted Nov 3, 2009·3 cites·1 claims
- 0669US10898471B2Methods of inhibiting leukotriene A4 hydrolaseCELLTAXIS LLC·Filed 2019·Granted Jan 26, 2021·0 cites·7 claims
- 0757US2024398793A1Methods of Treating LymphedemaCELLTAXIS LLC·Filed 2024·Application pending·0 cites
- 0856US2019161471A1Inhibitors of leukotriene a4 hydrolaseCELTAXSYS INC·Filed 2019·Application pending·0 cites
- 0956US2019161437A1Pendant amines and derivatives as inhibitors of leukotriene a4 hydrolaseCELTAXSYS INC·Filed 2019·Application pending·0 cites
- 1054US10202362B2Inhibitors of leukotriene A4 hydrolaseCELTAXSYS INC·Filed 2017·Granted Feb 12, 2019·0 cites·13 claims
- 1154US2022288034A1Method of reducing aberrant immune response or risk of progression in covid-19CELLTAXIS LLC·Filed 2022·Application pending·0 cites
- 1253US10202334B2Pendant amines and derivatives as inhibitors of leukotriene A4 hydrolaseCELTAXSYS INC·Filed 2017·Granted Feb 12, 2019·0 cites·11 claims
- 1349US10385007B2Monamine and monoamine derivatives as inhibitors of leukotriene A4 hydrolaseCELTAXSYS INC·Filed 2017·Granted Aug 20, 2019·0 cites·11 claims
- 1443US2007185098A1Inhibitors of protein kinasesLOCUS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1538US7741479B2Urea inhibitors of MAP kinasesLOCUS PHARMACEUTICALS INC·Filed 2005·Granted Jun 22, 2010·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Eric B. Springman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →